Skip to main content
Top
Published in: Arthritis Research & Therapy 4/2010

Open Access 01-08-2010 | Research article

Monocytes/macrophages express chemokine receptor CCR9 in rheumatoid arthritis and CCL25 stimulates their differentiation

Authors: Caroline Schmutz, Alison Cartwright, Helen Williams, Oliver Haworth, John HH Williams, Andrew Filer, Mike Salmon, Christopher D Buckley, Jim Middleton

Published in: Arthritis Research & Therapy | Issue 4/2010

Login to get access

Abstract

Introduction

Monocytes/macrophages accumulate in the rheumatoid (RA) synovium where they play a central role in inflammation and joint destruction. Identification of molecules involved in their accumulation and differentiation is important to inform therapeutic strategies. This study investigated the expression and function of chemokine receptor CCR9 in the peripheral blood (PB) and synovium of RA, non-RA patients and healthy volunteers.

Methods

CCR9 expression on PB monocytes/macrophages was analysed by flow cytometry and in synovium by immunofluorescence. Chemokine receptor CCR9 mRNA expression was examined in RA and non-RA synovium, monocytes/macrophages from PB and synovial fluid (SF) of RA patients and PB of healthy donors using the reverse transcription polymerase chain reaction (RT-PCR). Monocyte differentiation and chemotaxis to chemokine ligand 25 (CCL25)/TECK were used to study CCR9 function.

Results

CCR9 was expressed by PB monocytes/macrophages in RA and healthy donors, and increased in RA. In RA and non-RA synovia, CCR9 co-localised with cluster of differentiation 14+ (CD14+) and cluster of differentiation 68+ (CD68+) macrophages, and was more abundant in RA synovium. CCR9 mRNA was detected in the synovia of all RA patients and in some non-RA controls, and monocytes/macrophages from PB and SF of RA and healthy controls. CCL25 was detected in RA and non-RA synovia where it co-localised with CD14+ and CD68+ cells. Tumour necrosis factor alpha (TNFα) increased CCR9 expression on human acute monocytic leukemia cell line THP-1 monocytic cells. CCL25 induced a stronger monocyte differentiation in RA compared to healthy donors. CCL25 induced significant chemotaxis of PB monocytes but not consistently among individuals.

Conclusions

CCR9 expression by monocytes is increased in RA. CCL25 may be involved in the differentiation of monocytes to macrophages particularly in RA.
Appendix
Available only for authorised users
Literature
1.
go back to reference Sweeney SE, Firestein GS: Rheumatoid arthritis: regulation of synovial inflammation. Int J Biochem Cell Biol. 2004, 36: 372-378. 10.1016/S1357-2725(03)00259-0.CrossRefPubMed Sweeney SE, Firestein GS: Rheumatoid arthritis: regulation of synovial inflammation. Int J Biochem Cell Biol. 2004, 36: 372-378. 10.1016/S1357-2725(03)00259-0.CrossRefPubMed
2.
go back to reference Soden M, Rooney M, Whelan A, Feighery C, Bresnihan B: Immunohistochemical analysis of the synovial membrane: search for predictors of the clinical course in rheumatoid arthritis. Ann Rheum Dis. 1991, 50: 673-676. 10.1136/ard.50.10.673.PubMedCentralCrossRefPubMed Soden M, Rooney M, Whelan A, Feighery C, Bresnihan B: Immunohistochemical analysis of the synovial membrane: search for predictors of the clinical course in rheumatoid arthritis. Ann Rheum Dis. 1991, 50: 673-676. 10.1136/ard.50.10.673.PubMedCentralCrossRefPubMed
3.
go back to reference Mulherin D, Fitzgerald O, Bresnihan B: Synovial tissue macrophage populations and articular damage in rheumatoid arthritis. Arthritis Rheum. 1996, 39: 115-124. 10.1002/art.1780390116.CrossRefPubMed Mulherin D, Fitzgerald O, Bresnihan B: Synovial tissue macrophage populations and articular damage in rheumatoid arthritis. Arthritis Rheum. 1996, 39: 115-124. 10.1002/art.1780390116.CrossRefPubMed
4.
go back to reference Gerlag DM, Zwinderman AH, Smeets TJ, Kraan MC, Baeten D, McInnes IB, Bresnihan B, Tak PP: Synovial tissue macrophages: a sensitive biomarker for response to treatment in patients with rheumatoid arthritis. Ann Rheum Dis. 2005, 64: 834-838. 10.1136/ard.2004.029751.PubMedCentralCrossRefPubMed Gerlag DM, Zwinderman AH, Smeets TJ, Kraan MC, Baeten D, McInnes IB, Bresnihan B, Tak PP: Synovial tissue macrophages: a sensitive biomarker for response to treatment in patients with rheumatoid arthritis. Ann Rheum Dis. 2005, 64: 834-838. 10.1136/ard.2004.029751.PubMedCentralCrossRefPubMed
5.
go back to reference Yanni G, Nabil M, Farahat MR, Poston RN, Panayi GS: Intramuscular gold decreases cytokine expression and macrophage numbers in the rheumatoid synovial membrane. Ann Rheum Dis. 1994, 53: 315-322. 10.1136/ard.53.5.315.PubMedCentralCrossRefPubMed Yanni G, Nabil M, Farahat MR, Poston RN, Panayi GS: Intramuscular gold decreases cytokine expression and macrophage numbers in the rheumatoid synovial membrane. Ann Rheum Dis. 1994, 53: 315-322. 10.1136/ard.53.5.315.PubMedCentralCrossRefPubMed
6.
go back to reference Seitz M, Zwicker M, Loetscher P: Effects of methotrexate on differentiation of monocytes and production of cytokine inhibitors by monocytes. Arthritis Rheum. 1998, 41: 2032-2038. 10.1002/1529-0131(199811)41:11<2032::AID-ART19>3.0.CO;2-J.CrossRefPubMed Seitz M, Zwicker M, Loetscher P: Effects of methotrexate on differentiation of monocytes and production of cytokine inhibitors by monocytes. Arthritis Rheum. 1998, 41: 2032-2038. 10.1002/1529-0131(199811)41:11<2032::AID-ART19>3.0.CO;2-J.CrossRefPubMed
7.
go back to reference Sanmarti R, Marsal S, Valverde J, Casado E, Lafuente R, Kashiwagi N, Rodriguez-Cros JR, Erra A, Reina D, Gratacós J: Adsorptive granulocyte/monocyte apheresis for the treatment of refractory rheumatoid arthritis: an open pilot multicentre trial. Rheumatology (Oxford). 2005, 44: 1140-1144. 10.1093/rheumatology/keh701.CrossRef Sanmarti R, Marsal S, Valverde J, Casado E, Lafuente R, Kashiwagi N, Rodriguez-Cros JR, Erra A, Reina D, Gratacós J: Adsorptive granulocyte/monocyte apheresis for the treatment of refractory rheumatoid arthritis: an open pilot multicentre trial. Rheumatology (Oxford). 2005, 44: 1140-1144. 10.1093/rheumatology/keh701.CrossRef
8.
go back to reference Saniabadi AR, Hanai H, Takeuchi K, Umemura K, Nakashima M, Adachi T, Rodriguez-Cros JR, Erra A, Reina D, Gratacós J: Adacolumn, an adsorptive carrier based granulocyte and monocyte apheresis device for the treatment of inflammatory and refractory diseases associated with leukocytes. Ther Apher Dial. 2003, 7: 48-59. 10.1046/j.1526-0968.2003.00012.x.CrossRefPubMed Saniabadi AR, Hanai H, Takeuchi K, Umemura K, Nakashima M, Adachi T, Rodriguez-Cros JR, Erra A, Reina D, Gratacós J: Adacolumn, an adsorptive carrier based granulocyte and monocyte apheresis device for the treatment of inflammatory and refractory diseases associated with leukocytes. Ther Apher Dial. 2003, 7: 48-59. 10.1046/j.1526-0968.2003.00012.x.CrossRefPubMed
9.
go back to reference Feldmann M, Brennan FM, Foxwell BM, Taylor PC, Williams RO, Maini RN: Anti-TNF therapy: where have we got to in 2005?. J Autoimmun. 2005, 25 (Suppl): 26-28. 10.1016/j.jaut.2005.09.006.CrossRefPubMed Feldmann M, Brennan FM, Foxwell BM, Taylor PC, Williams RO, Maini RN: Anti-TNF therapy: where have we got to in 2005?. J Autoimmun. 2005, 25 (Suppl): 26-28. 10.1016/j.jaut.2005.09.006.CrossRefPubMed
10.
go back to reference Maruotti N, Cantatore FP, Crivellato E, Vacca A, Ribatti D: Macrophages in rheumatoid arthritis. Histol Histopathol. 2007, 22: 581-586.PubMed Maruotti N, Cantatore FP, Crivellato E, Vacca A, Ribatti D: Macrophages in rheumatoid arthritis. Histol Histopathol. 2007, 22: 581-586.PubMed
11.
go back to reference Haringman JJ, Kraan MC, Smeets TJ, Zwinderman KH, Tak PP: Chemokine blockade and chronic inflammatory disease: proof of concept in patients with rheumatoid arthritis. Ann Rheum Dis. 2003, 62: 715-721. 10.1136/ard.62.8.715.PubMedCentralCrossRefPubMed Haringman JJ, Kraan MC, Smeets TJ, Zwinderman KH, Tak PP: Chemokine blockade and chronic inflammatory disease: proof of concept in patients with rheumatoid arthritis. Ann Rheum Dis. 2003, 62: 715-721. 10.1136/ard.62.8.715.PubMedCentralCrossRefPubMed
12.
go back to reference Viola A, Luster AD: Chemokines and their receptors: drug targets in immunity and inflammation. Annu Rev Pharmacol Toxicol. 2008, 48: 171-197. 10.1146/annurev.pharmtox.48.121806.154841.CrossRefPubMed Viola A, Luster AD: Chemokines and their receptors: drug targets in immunity and inflammation. Annu Rev Pharmacol Toxicol. 2008, 48: 171-197. 10.1146/annurev.pharmtox.48.121806.154841.CrossRefPubMed
13.
go back to reference Koch AE: Chemokines and their receptors in rheumatoid arthritis: future targets?. Arthritis Rheum. 2005, 52: 710-721. 10.1002/art.20932.CrossRefPubMed Koch AE: Chemokines and their receptors in rheumatoid arthritis: future targets?. Arthritis Rheum. 2005, 52: 710-721. 10.1002/art.20932.CrossRefPubMed
14.
go back to reference Vergunst CE, Tak PP: Chemokines: their role in rheumatoid arthritis. Curr Rheumatol Rep. 2005, 7: 382-388. 10.1007/s11926-005-0026-7.CrossRefPubMed Vergunst CE, Tak PP: Chemokines: their role in rheumatoid arthritis. Curr Rheumatol Rep. 2005, 7: 382-388. 10.1007/s11926-005-0026-7.CrossRefPubMed
15.
go back to reference Zabel BA, Agace WW, Campbell JJ, Heath HM, Parent D, Roberts AI, Ebert EC, Kassam N, Qin S, Zovko M, LaRosa GJ, Yang LL, Soler D, Butcher EC, Ponath PD, Parker CM, Andrew DP: Human G protein-coupled receptor GPR-9-6/CC chemokine receptor 9 is selectively expressed on intestinal homing T lymphocytes, mucosal lymphocytes, and thymocytes and is required for thymus-expressed chemokine-mediated chemotaxis. J Exp Med. 1999, 190: 1241-1256. 10.1084/jem.190.9.1241.PubMedCentralCrossRefPubMed Zabel BA, Agace WW, Campbell JJ, Heath HM, Parent D, Roberts AI, Ebert EC, Kassam N, Qin S, Zovko M, LaRosa GJ, Yang LL, Soler D, Butcher EC, Ponath PD, Parker CM, Andrew DP: Human G protein-coupled receptor GPR-9-6/CC chemokine receptor 9 is selectively expressed on intestinal homing T lymphocytes, mucosal lymphocytes, and thymocytes and is required for thymus-expressed chemokine-mediated chemotaxis. J Exp Med. 1999, 190: 1241-1256. 10.1084/jem.190.9.1241.PubMedCentralCrossRefPubMed
16.
go back to reference Yu CR, Peden KW, Zaitseva MB, Golding H, Farber JM: CCR9A and CCR9B: two receptors for the chemokine CCL25/TECK/Ck beta-15 that differ in their sensitivities to ligand. J Immunol. 2000, 164: 1293-1305.CrossRefPubMed Yu CR, Peden KW, Zaitseva MB, Golding H, Farber JM: CCR9A and CCR9B: two receptors for the chemokine CCL25/TECK/Ck beta-15 that differ in their sensitivities to ligand. J Immunol. 2000, 164: 1293-1305.CrossRefPubMed
17.
go back to reference Kunkel EJ, Campbell JJ, Haraldsen G, Pan J, Boisvert J, Roberts AI, Ebert EC, Vierra MA, Goodman SB, Genovese MC, Wardlaw AJ, Greenberg HB, Parker CM, Butcher EC, Andrew DP, Agace WW: Lymphocyte CC chemokine receptor 9 and epithelial thymus-expressed chemokine (TECK) expression distinguish the small intestinal immune compartment: Epithelial expression of tissue-specific chemokines as an organizing principle in regional immunity. J Exp Med. 2000, 192: 761-768. 10.1084/jem.192.5.761.PubMedCentralCrossRefPubMed Kunkel EJ, Campbell JJ, Haraldsen G, Pan J, Boisvert J, Roberts AI, Ebert EC, Vierra MA, Goodman SB, Genovese MC, Wardlaw AJ, Greenberg HB, Parker CM, Butcher EC, Andrew DP, Agace WW: Lymphocyte CC chemokine receptor 9 and epithelial thymus-expressed chemokine (TECK) expression distinguish the small intestinal immune compartment: Epithelial expression of tissue-specific chemokines as an organizing principle in regional immunity. J Exp Med. 2000, 192: 761-768. 10.1084/jem.192.5.761.PubMedCentralCrossRefPubMed
18.
go back to reference Zaballos A, Gutierrez J, Varona R, Ardavin C, Marquez G: Cutting edge: identification of the orphan chemokine receptor GPR-9-6 as CCR9, the receptor for the chemokine TECK. J Immunol. 1999, 162: 5671-5675.PubMed Zaballos A, Gutierrez J, Varona R, Ardavin C, Marquez G: Cutting edge: identification of the orphan chemokine receptor GPR-9-6 as CCR9, the receptor for the chemokine TECK. J Immunol. 1999, 162: 5671-5675.PubMed
19.
go back to reference Uehara S, Hayes SM, Li L, El Khoury D, Canelles M, Fowlkes BJ, Love PE: Premature Expression of Chemokine Receptor CCR9 Impairs T Cell Development. J Immunol. 2006, 176: 75-84.CrossRefPubMed Uehara S, Hayes SM, Li L, El Khoury D, Canelles M, Fowlkes BJ, Love PE: Premature Expression of Chemokine Receptor CCR9 Impairs T Cell Development. J Immunol. 2006, 176: 75-84.CrossRefPubMed
20.
go back to reference Autschbach F, Funke B, Katzenmeier M, Gassler N: Expression of chemokine receptors in normal and inflamed human intestine, tonsil, and liver-An immunohistochemical analysis with new monoclonal antibodies from the 8th international workshop and conference on human leucocyte differentiation antigens. Cell Immunol. 2005, 236: 110-114. 10.1016/j.cellimm.2005.08.016.CrossRefPubMed Autschbach F, Funke B, Katzenmeier M, Gassler N: Expression of chemokine receptors in normal and inflamed human intestine, tonsil, and liver-An immunohistochemical analysis with new monoclonal antibodies from the 8th international workshop and conference on human leucocyte differentiation antigens. Cell Immunol. 2005, 236: 110-114. 10.1016/j.cellimm.2005.08.016.CrossRefPubMed
21.
go back to reference Qiuping Z, Qun L, Chunsong H, Xiaolian Z, Baojun H, Mingzhen Y, Chengming L, Jinshen H, Qingping G, Kejian Z, Zhimin S, Xuejun Z, Junyan L, Jinquan T: Selectively increased expression and functions of chemokine receptor CCR9 on CD4+ T cells from patients with T-cell lineage acute lymphocytic leukemia. Cancer Res. 2003, 63: 6469-6477.PubMed Qiuping Z, Qun L, Chunsong H, Xiaolian Z, Baojun H, Mingzhen Y, Chengming L, Jinshen H, Qingping G, Kejian Z, Zhimin S, Xuejun Z, Junyan L, Jinquan T: Selectively increased expression and functions of chemokine receptor CCR9 on CD4+ T cells from patients with T-cell lineage acute lymphocytic leukemia. Cancer Res. 2003, 63: 6469-6477.PubMed
22.
go back to reference Singh S, Singh UP, Stiles JK, Grizzle WE, Lillard JW: Expression and functional role of CCR9 in prostate cancer cell migration and invasion. Clin Cancer Res. 2004, 10: 8743-8750. 10.1158/1078-0432.CCR-04-0266.CrossRefPubMed Singh S, Singh UP, Stiles JK, Grizzle WE, Lillard JW: Expression and functional role of CCR9 in prostate cancer cell migration and invasion. Clin Cancer Res. 2004, 10: 8743-8750. 10.1158/1078-0432.CCR-04-0266.CrossRefPubMed
23.
go back to reference Vicari AP, Figueroa DJ, Hedrick JA, Foster JS, Singh KP, Menon S, Copeland NG, Gilbert DJ, Jenkins NA, Bacon KB, Zlotnik A: TECK: a novel CC chemokine specifically expressed by thymic dendritic cells and potentially involved in T cell development. Immunity. 1997, 7: 291-301. 10.1016/S1074-7613(00)80531-2.CrossRefPubMed Vicari AP, Figueroa DJ, Hedrick JA, Foster JS, Singh KP, Menon S, Copeland NG, Gilbert DJ, Jenkins NA, Bacon KB, Zlotnik A: TECK: a novel CC chemokine specifically expressed by thymic dendritic cells and potentially involved in T cell development. Immunity. 1997, 7: 291-301. 10.1016/S1074-7613(00)80531-2.CrossRefPubMed
24.
go back to reference Schmutz C, Hulme A, Burman A, Salmon M, Ashton B, Buckley C, Middleton J: Chemokine receptors in the rheumatoid synovium: up-regulation of CXCR5. Arthritis Res Ther. 2005, 7: R217-R229. 10.1186/ar1475.PubMedCentralCrossRefPubMed Schmutz C, Hulme A, Burman A, Salmon M, Ashton B, Buckley C, Middleton J: Chemokine receptors in the rheumatoid synovium: up-regulation of CXCR5. Arthritis Res Ther. 2005, 7: R217-R229. 10.1186/ar1475.PubMedCentralCrossRefPubMed
25.
go back to reference Patterson AM, Gardner L, Shaw J, David G, Loreau E, Aguilar L, Ashton BA, Middleton J: Induction of a CXCL8 binding site on endothelial syndecan-3 in the rheumatoid synovium. Arthritis Rheum. 2005, 52: 2331-2342. 10.1002/art.21222.CrossRefPubMed Patterson AM, Gardner L, Shaw J, David G, Loreau E, Aguilar L, Ashton BA, Middleton J: Induction of a CXCL8 binding site on endothelial syndecan-3 in the rheumatoid synovium. Arthritis Rheum. 2005, 52: 2331-2342. 10.1002/art.21222.CrossRefPubMed
26.
go back to reference Burman A, Haworth O, Hardie DL, Amft EN, Siewert C, Jackson DG, Salmon M, Buckley CD: A chemokine-dependent stromal induction mechanism for aberrant lymphocyte accumulation and compromised lymphatic return in rheumatoid arthritis. J Immunol. 2005, 174: 1693-1700.PubMedCentralCrossRefPubMed Burman A, Haworth O, Hardie DL, Amft EN, Siewert C, Jackson DG, Salmon M, Buckley CD: A chemokine-dependent stromal induction mechanism for aberrant lymphocyte accumulation and compromised lymphatic return in rheumatoid arthritis. J Immunol. 2005, 174: 1693-1700.PubMedCentralCrossRefPubMed
27.
go back to reference Twisk JSR: Applied Multilevel Analysis: A Practical Guide for Medical Researchers. 2006, Cambridge: Cambridge University PressCrossRef Twisk JSR: Applied Multilevel Analysis: A Practical Guide for Medical Researchers. 2006, Cambridge: Cambridge University PressCrossRef
28.
go back to reference Gelman A, Hill J: Data Analysis Using Regression and Multilevel/Hierarchical Models. 2006, Cambridge: Cambridge University PressCrossRef Gelman A, Hill J: Data Analysis Using Regression and Multilevel/Hierarchical Models. 2006, Cambridge: Cambridge University PressCrossRef
29.
go back to reference Kawanaka N, Yamamura M, Aita T, Morita Y, Okamoto A, Kawashima M, Iwahashi M, Ueno A, Ohmoto Y, Makino H: CD14+, CD16+ blood monocytes and joint inflammation in rheumatoid arthritis. Arthritis Rheum. 2002, 46: 2578-2586. 10.1002/art.10545.CrossRefPubMed Kawanaka N, Yamamura M, Aita T, Morita Y, Okamoto A, Kawashima M, Iwahashi M, Ueno A, Ohmoto Y, Makino H: CD14+, CD16+ blood monocytes and joint inflammation in rheumatoid arthritis. Arthritis Rheum. 2002, 46: 2578-2586. 10.1002/art.10545.CrossRefPubMed
30.
go back to reference Ruth JH, Haas CS, Park CC, Amin MA, Martinez RJ, Haines GK, Shahrara S, Campbell PL, Koch AE: CXCL16-mediated cell recruitment to rheumatoid arthritis synovial tissue and murine lymph nodes is dependent upon the MAPK pathway. Arthritis Rheum. 2006, 54: 765-778. 10.1002/art.21662.PubMedCentralCrossRefPubMed Ruth JH, Haas CS, Park CC, Amin MA, Martinez RJ, Haines GK, Shahrara S, Campbell PL, Koch AE: CXCL16-mediated cell recruitment to rheumatoid arthritis synovial tissue and murine lymph nodes is dependent upon the MAPK pathway. Arthritis Rheum. 2006, 54: 765-778. 10.1002/art.21662.PubMedCentralCrossRefPubMed
31.
go back to reference Hansson GK, Robertson AK, Söderberg-Nauclér C: Inflammation and atherosclerosis. Annu Rev Pathol. 2006, 1: 297-329. 10.1146/annurev.pathol.1.110304.100100.CrossRefPubMed Hansson GK, Robertson AK, Söderberg-Nauclér C: Inflammation and atherosclerosis. Annu Rev Pathol. 2006, 1: 297-329. 10.1146/annurev.pathol.1.110304.100100.CrossRefPubMed
32.
go back to reference Ren Y, Silverstein RL, Allen J, Savill J: CD36 gene transfer confers capacity for phagocytosis of cells undergoing apoptosis. J Exp Med. 1995, 181: 1857-1862. 10.1084/jem.181.5.1857.CrossRefPubMed Ren Y, Silverstein RL, Allen J, Savill J: CD36 gene transfer confers capacity for phagocytosis of cells undergoing apoptosis. J Exp Med. 1995, 181: 1857-1862. 10.1084/jem.181.5.1857.CrossRefPubMed
33.
go back to reference Plüddemann A, Neyen C, Gordon S: Macrophage scavenger receptors and host derived ligands. Methods. 2007, 43: 207-217. 10.1016/j.ymeth.2007.06.004.CrossRefPubMed Plüddemann A, Neyen C, Gordon S: Macrophage scavenger receptors and host derived ligands. Methods. 2007, 43: 207-217. 10.1016/j.ymeth.2007.06.004.CrossRefPubMed
34.
go back to reference Selvi E, Manganelli S, De Stefano R, Frati E, Marcolongo R: CD36 and CD14 immunoreactivity of Reiter cells in inflammatory synovial fluids. Ann Rheum Dis. 2000, 59: 399-400. 10.1136/ard.59.5.399.PubMedCentralCrossRefPubMed Selvi E, Manganelli S, De Stefano R, Frati E, Marcolongo R: CD36 and CD14 immunoreactivity of Reiter cells in inflammatory synovial fluids. Ann Rheum Dis. 2000, 59: 399-400. 10.1136/ard.59.5.399.PubMedCentralCrossRefPubMed
35.
go back to reference Zhou L, Shen LH, Hu LH, Ge H, Pu J, Chai DJ, Shao Q, Wang L, Zeng JZ, He B: Retinoid X receptor agonists inhibit phorbol-12-mystrate-13-acetate (PMA)-induced differentiation of monocytic THP-1 cells into macrophages. Mol Cell Biochem. 2009, 335: 283-289. 10.1007/s11010-009-0278-z.CrossRefPubMed Zhou L, Shen LH, Hu LH, Ge H, Pu J, Chai DJ, Shao Q, Wang L, Zeng JZ, He B: Retinoid X receptor agonists inhibit phorbol-12-mystrate-13-acetate (PMA)-induced differentiation of monocytic THP-1 cells into macrophages. Mol Cell Biochem. 2009, 335: 283-289. 10.1007/s11010-009-0278-z.CrossRefPubMed
36.
go back to reference Gleissner CA, von Hundelshausen P, Ley K: Platelet chemokines in vascular disease. Arterioscler Thromb Vasc Biol. 2008, 28: 1920-1927. 10.1161/ATVBAHA.108.169417.PubMedCentralCrossRefPubMed Gleissner CA, von Hundelshausen P, Ley K: Platelet chemokines in vascular disease. Arterioscler Thromb Vasc Biol. 2008, 28: 1920-1927. 10.1161/ATVBAHA.108.169417.PubMedCentralCrossRefPubMed
37.
go back to reference Szekanecz Z, Koch AE, Kunkel SL, Strieter RM: Cytokines in rheumatoid arthritis. Potential targets for pharmacological intervention. Drugs Aging. 1998, 12: 377-390. 10.2165/00002512-199812050-00004.CrossRefPubMed Szekanecz Z, Koch AE, Kunkel SL, Strieter RM: Cytokines in rheumatoid arthritis. Potential targets for pharmacological intervention. Drugs Aging. 1998, 12: 377-390. 10.2165/00002512-199812050-00004.CrossRefPubMed
38.
go back to reference Tanabe M, Ochi T, Tomita T, Suzuki R, Sakata T, Shimaoka Y, Nakagawa S, Ono K: Remarkable elevation of interleukin 6 and interleukin 8 levels in the bone marrow serum of patients with rheumatoid arthritis. J Rheumatol. 1994, 21: 830-835.PubMed Tanabe M, Ochi T, Tomita T, Suzuki R, Sakata T, Shimaoka Y, Nakagawa S, Ono K: Remarkable elevation of interleukin 6 and interleukin 8 levels in the bone marrow serum of patients with rheumatoid arthritis. J Rheumatol. 1994, 21: 830-835.PubMed
39.
go back to reference Tomita T, Kashiwagi N, Shimaoka Y, Ikawa T, Tanabe M, Nakagawa S, Kawamura S, Denno K, Owaki H, Ochi T: Phenotypic characteristics of bone marrow cells in patients with rheumatoid arthritis. J Rheumatol. 1994, 21: 1608-1614.PubMed Tomita T, Kashiwagi N, Shimaoka Y, Ikawa T, Tanabe M, Nakagawa S, Kawamura S, Denno K, Owaki H, Ochi T: Phenotypic characteristics of bone marrow cells in patients with rheumatoid arthritis. J Rheumatol. 1994, 21: 1608-1614.PubMed
40.
go back to reference Jimenez-Boj E, Redlich K, Türk B, Hanslik-Schnabel B, Wanivenhaus A, Chott A, Smolen JS, Schett G: Interaction between synovial inflammatory tissue and bone marrow in rheumatoid arthritis. J Immunol. 2005, 175: 2579-2588.CrossRefPubMed Jimenez-Boj E, Redlich K, Türk B, Hanslik-Schnabel B, Wanivenhaus A, Chott A, Smolen JS, Schett G: Interaction between synovial inflammatory tissue and bone marrow in rheumatoid arthritis. J Immunol. 2005, 175: 2579-2588.CrossRefPubMed
41.
go back to reference Papadakis KA, Prehn J, Nelson V, Cheng L, Binder SW, Ponath PD, Andrew DP, Targan SR: The role of thymus-expressed chemokine and its receptor CCR9 on lymphocytes in the regional specialization of the mucosal immune system. J Immunol. 2000, 165: 5069-5076.CrossRefPubMed Papadakis KA, Prehn J, Nelson V, Cheng L, Binder SW, Ponath PD, Andrew DP, Targan SR: The role of thymus-expressed chemokine and its receptor CCR9 on lymphocytes in the regional specialization of the mucosal immune system. J Immunol. 2000, 165: 5069-5076.CrossRefPubMed
42.
go back to reference Papadakis KA, Prehn J, Moreno ST, Cheng L, Kouroumalis EA, Deem R, Breaverman T, Ponath PD, Andrew DP, Green PH, Hodge MR, Binder SW, Targan SR: CCR9-positive lymphocytes and thymus-expressed chemokine distinguish small bowel from colonic Crohn's disease. Gastroenterology. 2001, 121: 246-254. 10.1053/gast.2001.27154.CrossRefPubMed Papadakis KA, Prehn J, Moreno ST, Cheng L, Kouroumalis EA, Deem R, Breaverman T, Ponath PD, Andrew DP, Green PH, Hodge MR, Binder SW, Targan SR: CCR9-positive lymphocytes and thymus-expressed chemokine distinguish small bowel from colonic Crohn's disease. Gastroenterology. 2001, 121: 246-254. 10.1053/gast.2001.27154.CrossRefPubMed
43.
go back to reference Svensson M, Marsal J, Ericsson A, Carramolino L, Brodén T, Márquez G, Agace WW: CCL25 mediates the localization of recently activated CD8alphabeta(+. lymphocytes to the small-intestinal mucosa. J Clin Invest. 2002, 110: 1113-1121.PubMedCentralCrossRefPubMed Svensson M, Marsal J, Ericsson A, Carramolino L, Brodén T, Márquez G, Agace WW: CCL25 mediates the localization of recently activated CD8alphabeta(+. lymphocytes to the small-intestinal mucosa. J Clin Invest. 2002, 110: 1113-1121.PubMedCentralCrossRefPubMed
44.
go back to reference Johansson-Lindbom B, Svensson M, Wurbel MA, Malissen B, Márquez G, Agace W: Selective generation of gut tropic T cells in gut-associated lymphoid tissue (GALT): requirement for GALT dendritic cells and adjuvant. J Exp Med. 2003, 198: 963-969. 10.1084/jem.20031244.PubMedCentralCrossRefPubMed Johansson-Lindbom B, Svensson M, Wurbel MA, Malissen B, Márquez G, Agace W: Selective generation of gut tropic T cells in gut-associated lymphoid tissue (GALT): requirement for GALT dendritic cells and adjuvant. J Exp Med. 2003, 198: 963-969. 10.1084/jem.20031244.PubMedCentralCrossRefPubMed
45.
go back to reference Ruth JH, Rottman JB, Katschke KJ, Qin S, Wu L, LaRosa G, Ponath P, Pope RM, Koch AE: Selective lymphocyte chemokine receptor expression in the rheumatoid joint. Arthritis Rheum. 2001, 44: 2750-2760. 10.1002/1529-0131(200112)44:12<2750::AID-ART462>3.0.CO;2-C.CrossRefPubMed Ruth JH, Rottman JB, Katschke KJ, Qin S, Wu L, LaRosa G, Ponath P, Pope RM, Koch AE: Selective lymphocyte chemokine receptor expression in the rheumatoid joint. Arthritis Rheum. 2001, 44: 2750-2760. 10.1002/1529-0131(200112)44:12<2750::AID-ART462>3.0.CO;2-C.CrossRefPubMed
46.
go back to reference Kunkel EJ, Campbell DJ, Butcher EC: Chemokines in lymphocyte trafficking and intestinal immunity. Microcirculation. 2003, 10: 313-323.CrossRefPubMed Kunkel EJ, Campbell DJ, Butcher EC: Chemokines in lymphocyte trafficking and intestinal immunity. Microcirculation. 2003, 10: 313-323.CrossRefPubMed
47.
go back to reference Wurbel MA, Philippe JM, Nguyen C, Victorero G, Freeman T, Wooding P, Miazek A, Mattei MG, Malissen M, Jordan BR, Malissen B, Carrier A, Naquet P: The chemokine TECK is expressed by thymic and intestinal epithelial cells and attracts double- and single-positive thymocytes expressing the TECK receptor CCR9. Eur J Immunol. 2000, 30: 262-271. 10.1002/1521-4141(200001)30:1<262::AID-IMMU262>3.0.CO;2-0.CrossRefPubMed Wurbel MA, Philippe JM, Nguyen C, Victorero G, Freeman T, Wooding P, Miazek A, Mattei MG, Malissen M, Jordan BR, Malissen B, Carrier A, Naquet P: The chemokine TECK is expressed by thymic and intestinal epithelial cells and attracts double- and single-positive thymocytes expressing the TECK receptor CCR9. Eur J Immunol. 2000, 30: 262-271. 10.1002/1521-4141(200001)30:1<262::AID-IMMU262>3.0.CO;2-0.CrossRefPubMed
48.
go back to reference Jacobs JP, Ortiz-Lopez A, Campbell JJ, Gerard CJ, Mathis D, Benoist C: Deficiency of CXCR2, but not other chemokine receptors, attenuates a murine model of autoantibody-mediated arthritis. Arthritis Rheum. 2010, 62: 1921-1932.PubMedCentralPubMed Jacobs JP, Ortiz-Lopez A, Campbell JJ, Gerard CJ, Mathis D, Benoist C: Deficiency of CXCR2, but not other chemokine receptors, attenuates a murine model of autoantibody-mediated arthritis. Arthritis Rheum. 2010, 62: 1921-1932.PubMedCentralPubMed
49.
go back to reference Eksteen B, Adams DH: GSK-1605786, a selective small-molecule antagonist of the CCR9 chemokine receptor for the treatment of Crohn's disease. IDrugs. 2010, 13: 472-481.PubMed Eksteen B, Adams DH: GSK-1605786, a selective small-molecule antagonist of the CCR9 chemokine receptor for the treatment of Crohn's disease. IDrugs. 2010, 13: 472-481.PubMed
50.
go back to reference Proudfoot AE, Power CA, Schwarz MK: Anti-chemokine small molecule drugs: a promising future?. Expert Opin Investig Drugs. 2010, 19: 345-355. 10.1517/13543780903535867.CrossRefPubMed Proudfoot AE, Power CA, Schwarz MK: Anti-chemokine small molecule drugs: a promising future?. Expert Opin Investig Drugs. 2010, 19: 345-355. 10.1517/13543780903535867.CrossRefPubMed
51.
go back to reference Szekanecz Z, Koch AE: Macrophages and their products in rheumatoid arthritis. Curr Opin Rheumatol. 2007, 19: 289-295. 10.1097/BOR.0b013e32805e87ae.CrossRefPubMed Szekanecz Z, Koch AE: Macrophages and their products in rheumatoid arthritis. Curr Opin Rheumatol. 2007, 19: 289-295. 10.1097/BOR.0b013e32805e87ae.CrossRefPubMed
Metadata
Title
Monocytes/macrophages express chemokine receptor CCR9 in rheumatoid arthritis and CCL25 stimulates their differentiation
Authors
Caroline Schmutz
Alison Cartwright
Helen Williams
Oliver Haworth
John HH Williams
Andrew Filer
Mike Salmon
Christopher D Buckley
Jim Middleton
Publication date
01-08-2010
Publisher
BioMed Central
Published in
Arthritis Research & Therapy / Issue 4/2010
Electronic ISSN: 1478-6362
DOI
https://doi.org/10.1186/ar3120

Other articles of this Issue 4/2010

Arthritis Research & Therapy 4/2010 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.